Latest news
News
-
20 June 2017
Several Biologics Approved to Treat Psoriasis in Children
NICE has published its decision to recommend Adalimumab, Etanercept and Stelara (Ustekinumab) for the treatment of children with severe psoriasis.
-
16 May 2017
Our Achievements 2016 Published
Download and read our 2016 Annual Review
-
11 May 2017
Four Successful Applications in 2017 Research Grant Funding Round
The Psoriasis Association is funding three PhD Studentship Grants and one Small Grant in the latest funding round.
-
19 April 2017
Cimzia & Cosentyx - New Biologic Treatments Approved for Psoriatic Arthritis
Cimzia (Certolizumab Pegol) and Cosentyx (Secukinumab) get the go-ahead from NICE.
-
10 April 2017
Taltz (Ixekizumab) - New Biologic Treatment Approved for Psoriasis in Scotland
Taltz (Ixekizumab) has been approved by the Scottish Medicines Consortium.